Details of the Drug

General Information of Drug (ID: DM0YL3Y)

• Drug Name: Mirvetuximab soratansine

Indication

Disease Entry	ICD 11	Status	REF
Ovarian cancer	2C73	Phase 2	[1]

• Cross-matching ID: TTD ID: D0V9EX

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)